Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member
  • MB Vision
  • Members
    • Become a Member
      • Types & Rates
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Career Center
    • Directory
    • Pay Company Dues
    • FAQs
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • The State of Possible Conference
    • Align Summit
    • Member Events
  • Innovation
    • About
    • Drive
      • Application
      • Alumni
      • Partners – MassBio
      • Partners – SCbio
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady® Communities
    • Workforce Development
      • Bioversity
    • Vision 2030
    • This is the place.
    • Industry Reports
      • Federal Actions Impact Report
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • News & Thought Leadership
    • MB Vision
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member
  • MB Vision
Open search form

Member Directory

Click to Open Main Menu

MannKind Corporation

Life Sciences | Drug Development
Bedford, MA 203-798-8000 Website

Overview

MannKind Corporation is a biopharmaceutical company focused on developing and commercializing therapeutics for diseases including diabetes, cancer, inflammatory, and autoimmune diseases. MannKind Corporation operates two business units, MannKind Immunology and MannKind Biopharmaceuticals. MannKind Immunology is focused on developing agents to treat cancer as well as a variety of inflammatory and autoimmune diseases. The corporate headquarters and MannKind Immunology are located in Valencia, California.

MannKind Biopharmaceuticals is located in Danbury, Connecticut, which is the location of our Technosphere® Insulin research, development and manufacturing. Our lead product candidate, which is currently in Phase IIb clinical trials, is a new-generation pulmonary insulin system for the treatment of diabetes. This system is based on our proprietary Technosphere® technology, which is being developed with the goal of providing a wide range of alternatives for non-invasive pulmonary drug delivery of therapeutic agents that currently require invasive administration.

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • © 2025 All Rights Reserved